Introduction
Many native Australian plants, including Syzygium spp., have been used as traditional medicines by indigenous Australians; however, they have been underutilised in modern medicine due to a lack of scientific studies. The berries of Syzygium smithii, commonly known as lilly pilly, are considered to be a protective food and have not been investigated previously. This is a preliminary study of the antimicrobial and antioxidant properties of the berries and leaves of Syzygium smithii.
Method
Syzygium smithii berries and leaves were extracted using an in-house cold extraction method in ethanol and water. Their antimicrobial properties were investigated using disc diffusion and minimum inhibitory concentration (MIC) assays against Gram-positive (Bacillus cereus, Enterococcus faecalis, Listeria monocytogenes, Staphylococcus aureus) and Gram-negative (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella enterica) bacteria. Their antioxidant capacity was investigated using 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical inhibition, ferric reducing antioxidant power (FRAP), total phenolic content (TPC), and total flavonoid content (TFC) assays.
Results
During the disc diffusion assay, the ethanolic berry and leaf extracts showed inhibitory potential against all Gram-positive bacteria, except for S. aureus for the berry extract. The MIC of the ethanolic leaf extract was found to be 25 mg/ml against all bacteria excluding S. enterica, and that of the aqueous leaf extract was between 12.5 and 25 mg/ml against all bacteria excluding K. pneumoniae and S. enterica. TPC and TFC were found to be 663.44 µg gallic acid/mg and 489.80 µg quercetin/mg, respectively, and the antioxidant capacity of the aqueous berry extract had an IC50 of 38.79 µg/ml against DPPH.
Conclusion
In conclusion, Syzygium smithii has the potential to be utilised by modern medicine as a potential antimicrobial and antioxidant agent. Further studies are needed to confirm these biological activities of Syzygium smithii.
